Raymond James Financial Services Advisors, Inc. Cor Medix Inc. Transaction History

Raymond James Financial Services Advisors, Inc.

$66.3 Billion
Q1 2024

A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Cor Medix Inc. stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 83,295 shares of CRMD stock, worth $360,667. This represents 0.0% of its overall portfolio holdings.

Number of Shares

83,295

Previous 81,834 1.79%

Holding current value

$360,667

Previous $307,000 14.98%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 22, 2024	BUY	$2.94 - $4.24 $4,295 - $6,194	1,461 Added 1.79%	83,295 $353,000
Q4 2023 Jan 16, 2024	BUY	$3.0 - $4.01 $31,086 - $41,551	10,362 Added 14.5%	81,834 $307,000
Q3 2023 Oct 24, 2023	SELL	$3.6 - $4.46 $2,808 - $3,478	-780 Reduced 1.08%	71,472 $264,000
Q2 2023 Jul 25, 2023	SELL	$3.94 - $5.8 $197 - $290	-50 Reduced 0.07%	72,252 $286,000
Q1 2023 Apr 14, 2023	SELL	$3.22 - $4.61 $1,626 - $2,328	-505 Reduced 0.69%	72,302 $299,000

Q4 2022 Feb 08, 2023	BUY	$2.83 - $4.45 $69,052 - $108,580	24,400 Added 50.41%	72,807 $307,000
Q3 2022 Oct 25, 2022	BUY	$2.88 - $7.52 $17,386 - $45,398	6,037 Added 14.25%	48,407 $137,000
Q2 2022 Aug 12, 2022	BUY	$2.73 - $5.61 $9,159 - $18,821	3,355 Added 8.6%	42,370 $170,000
Q1 2022 May 11, 2022	SELL	$3.83 - $6.24 $11,547 - $18,813	-3,015 Reduced 7.17%	39,015 $214,000
Q4 2021 Feb 08, 2022	SELL	$4.47 - $5.56 $9,753 - $12,131	-2,182 Reduced 4.94%	42,030 $191,000
Q3 2021 Nov 02, 2021	BUY	$4.46 - $7.11 $3,099 - $4,941	695 Added 1.6%	44,212 $206,000
Q2 2021 Aug 11, 2021	BUY	$6.05 - $10.09 $7,629 - $12,723	1,261 Added 2.98%	43,517 $299,000
Q1 2021 May 14, 2021	BUY	$6.84 - $17.58 $116,184 - $298,613	16,986 Added 67.22%	42,256 $422,000
Q4 2020 Feb 12, 2021	SELL	$5.0 - $9.15 $300 - $549	-60 Reduced 0.24%	25,270 $188,000
Q3 2020 Nov 04, 2020	BUY	$3.96 - $6.15 $2,296 - $3,567	580 Added 2.34%	25,330 $153,000
Q2 2020 Jul 17, 2020	BUY	$3.08 - $6.56 $2,310 - $4,920	750 Added 3.13%	24,750 $156,000
Q1 2020 Apr 21, 2020	BUY	$2.35 - $7.08 $8,965 - $27,010	3,815 Added 18.9%	24,000 $86,000
Q4 2019 Feb 12, 2020	BUY	$4.96 - $7.75 $2,088 - $3,262	421 Added 2.13%	20,185 $147,000
Q3 2019 Nov 07, 2019	BUY	$6.38 - $9.69 $9,340 - $14,186	1,464 Added 8.0%	19,764 $126,000
Q2 2019 Aug 06, 2019	BUY	$5.93 - $10.57 $38,776 - $69,117	6,539 Added 55.6%	18,300 $164,000
Q1 2019 May 06, 2019	BUY	$6.95 - $13.25 $81,738 - $155,833	11,761 New	11,761 $111,000

Others Institutions Holding CRMD

# of Institutions

Shares Held

17.1M

Call Options Held

92.9K

Put Options Held

293K

View Full List

About CorMedix Inc.

Ticker CRMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,208,200
Market Cap $178M
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...

More about CRMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account

Raymond James Financial Services Advisors, Inc. Cor Medix Inc. Transaction History